Work

Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer’s Disease

Year: 2016

Type: review

Source: Drugs

DOI: 10.1007/s40265-016-0674-0

Author: Suzanne M. de la Monte

Institutions: Brown University, Rhode Island Hospital

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Novo Nordisk, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute on Aging

Awards: G2072087434, Clinical Evaluation of T3D-959 as a Potential Disease Remedial Therapeutic for the Treatment of Alzheimer's Disease, G4540679723, ETHANOL, INSULIN/IGF SIGNALING AND NEURONAL MIGRATION, Ethanol, IRS-1 Signaling and Neuronal Migration, FASD Inhibition of ASPH-Notch Mediates Adolescent Cerebral White Matter Pathology-Potential Utility of Non-invasive Extracellular Vesicle Assays

OpenAlex ID: W2563087870

FWCI: 2.317

Cites: 267

Cited by: 334

Related to: 10